HCR 553: Quality in Manufacturing Product Control Product Control Any clinical trial’s success, safety, and integrity depend greatly on the quality of investigational medical products produced during manufacturing. Those working in clinical settings stay away from manufacturing processes, and their understanding of controlling the products is necessary for the care of participants. In today’s organizations, […]
HCR 553 Quality Management Plan Phase III Study: XYZ vs. Corticosteroids for Lateral Epicondylitis Overview and Summary of the Plan The present Quality Management Plan (QMP) is a straightforward plan designed to support the integrity and quality of a Phase III randomized, double-blind, multi-center clinical trial. This trial involves the investigational product XYZ compared with […]
Module 4 Discussion Board 4 HCR 553 Selected Commitment from Section 9 of Form FDA 1572: “I agree to inform any patients, or any persons used as controls, that the drugs are being used for investigational purposes and I will ensure that the requirements relating to obtaining informed consent in 21 CFR Part 50 and […]
HCR 561 Discussion Board 5 Not all researchers are fully equipped to determine when a participant has diminished decision-making capacity. Investigators and coordinators are often trained in clinical procedures but are not trained in recognizing cognitive impairments. Laura Holtz highlights that these determinations can be made effectively by the frontline research staff, particularly the coordinators, […]
HCR 561 Module 5 Essay Inclusion of Mentally Incapacitated Individuals in Research Mentally incapacitated individuals are a vulnerable group in research. They include individuals with dementia, psychiatric conditions, impairments in cognition, or head trauma. These conditions have the potential to prevent their understanding of study procedures or informed consent. As a result, they become susceptible […]
HCR 553 Module 5 Quality in Clinical Trials Introduction Yes! The use of digital pills in clinical trials is a promising innovation. The antipsychotic drug aripiprazole, in combination with an ingestible sensor developed by Proteus Health and Otsuka, illustrates how technology can help solve long-term issues in research. Ensuring that the participants follow the prescription […]
HCR 553 Module 5 Six Sigma Article Summary Kwak and Anbari’s (2006) article, “Benefits, Obstacles, and Future of Six Sigma Approach”, does a thorough analysis of the six-sigma methodology as a data-driven strategy of a quality improvement system in an organizational context, such as in healthcare. Six Sigma originated in the manufacturing sector as a […]
Module 6 HCR 553 Discussion Post As the Quality Manager of our Clinical study site, choosing a compliant and efficient Clinical Trial Management System (CTMS) is a very important task. The CTMS should be able to comply with the regulatory standards of 21 CFR Part 11, which governs the use of electronic records and electronic […]
Article Review Module 6 HCR 553 Article under Review: https://www.healthline.com/health-news/why-this-fda-approved-drug-for-pre-term-birth-is-being-pulled-from-the-market Introduction The Food and Drug Administration (FDA) has a significant role in safeguarding the health of the people. It does this by checking the data in clinical trials in an effort to decide on the safety and efficacy of a drug. Nonetheless, there have been […]
HCR 576: AI and the Future of Custom-Made Proteins in Drug Development Medical science is undergoing a powerful transformation with artificial intelligence (AI) that allows for the design of custom-designed proteins, including constrained peptides, which are highly stable and potent with versatile properties that make them ideal in medical applications (Mak et al., 2024). This […]
